Abnormal activity of BTK is observed in a range of B-cell malignancies, including Waldenström macroglobulinemia (WM), chronic lymphocytic leukemia (CLL), and mantle cell lymphoma (MCL) [1, 2]. Here, BTK is linked to mantle cell lymphoma.